ACHN
Achillion Pharmaceuticals
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
114 hedge funds and large institutions have $294M invested in Achillion Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 30 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less capital invested
Capital invested by funds: $326M → $294M (-$31.5M)
Holders
114
Holding in Top 10
1
Calls
$291K
Puts
$154K
Top Buyers
| 1 | +$7.81M | |
| 2 | +$4.89M | |
| 3 | +$3.38M | |
| 4 |
Morgan Stanley
New York
|
+$2.04M |
| 5 |
Renaissance Technologies
New York
|
+$1.95M |
Top Sellers
| 1 | -$7.4M | |
| 2 | -$2.61M | |
| 3 | -$2.19M | |
| 4 |
Axa
Paris,
France
|
-$1.67M |
| 5 |
Goldman Sachs
New York
|
-$1.57M |